( October 23, 2026, 12:38 GMT | Official Statement) -- MLex Summary: Pharmaceutical company Merck Sharp & Dohme is the target of an investigation opened by the Romanian competition authority into whether the business abused its market power. The watchdog said on Friday it would investigate whether MSD refused to cooperate with Dona.Logistica, restricting its access to the distribution of five drugs in Romania: Janumet, Januvia, Remicade, Simponi and Keytruda. Antitrust officials have carried out a surprise inspection at the company's headquarters in Bucharest, the authority said.Statement follows (in Romanian). ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.